Editorial: Management of active infective endocarditis complicated by large vegetations

Journal of Heart Valve Disease

Volumn 15, Issue 4, 2006, Pages 563-566

  Horstkotte, Dieter ^a   Piper, Cornelia ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ABIOTROPHIA; ALPHA HEMOLYTIC STREPTOCOCCUS; AORTA VALVE; BACTERIAL ENDOCARDITIS; DISEASE ACTIVITY; ECHOCARDIOGRAPHY; EDITORIAL; EMBOLISM; HIGH RISK PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MITRAL VALVE; NOCARDIA; NONHUMAN; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS BOVIS; DRUG EFFECT; ECHOGRAPHY; HEART VALVE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NOTE; PATHOGENICITY; PATHOLOGY; PROGNOSIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TIME; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANTI-BACTERIAL AGENTS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM; ENDOCARDITIS, BACTERIAL; HEART VALVES; HUMANS; MICROBIAL SENSITIVITY TESTS; PROGNOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS BOVIS; TIME FACTORS;

EID: 33746441973     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Haines SA, Astroulakis Z, Bahrami T, Archbold RA. Early surgery or medical treatment in endocarditis complicated by embolism from a large, mobile vegetation? A case-based discussion. J Heart Valve Dis 2006;15:567-569
2. Horstkotte D. Infective endocarditis. Steinkopff, Darmstadt, 1995
3. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-2948
4. Jaffe WM, Morgan DE, Pearlman AS, et al. Infective endocarditis 1983-1988: Echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardiol 1990;15:1227-1233
5. Reinhartz O, Herrmann M, Redling F, et al. Timing of surgery in patients with acute infective endocarditis. J Cardiovasc Surg 1996;37:397-400
6. Horstkotte D, Bircks W, Loogen F. Infective endocarditis of native and prosthetic valves - the case for prompt surgical intervention? Z Kardiol 1986;75(Suppl.2):168-182
7. Habib G. Embolic risk in subacute bacterial endocarditis: Role of transesophageal echocardiography. Curr Cardiol Rep 2003;5:129-136
8. Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001;142:75-80
9. Thuny F, Disalvo G, Belliard O, et al. Risk of embolism and death in infective endocarditis: Prognostic value of echocardiography. A prospective multicenter study. Circulation 2005;12:69-75
10. Vuille C, Nidorf M, Weyman AE, Picard MH. Natural history of vegetations during successful medical treatment of endocarditis. Am Heart J 1994;128:1200-1209
11. Heinle S, Wilderman N, Harrison K, et al. Value of transthoracic echocardiography in predicting embolic events in active native endocarditis. Duke Endocarditis Service. Am J Cardiol 1994;74:799-801
12. Mügge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989;14:631-638
13. Mangoni ED, Adinolfi LE, Tripodi MF, et al. Risk factors for 'major' embolic events in hospitalized patients with infective endocarditis. Am Heart J 2003;146:311-316
14. Siddiq S, Missri J, Silverman DI. Endocarditis in an urban hospital in the 1990s. Arch Intern Med 1996;156:2454-2458
15. Koie S, Iwase M, Hasegawa K, et al. Echocardiographic prediction of risk for embolism in patients with infective endocarditis. J Cardiol 1997;29(Suppl.):117-122
16. Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications: A meta-analysis. J Am Soc Echocardiogr 1997;10:562-568
17. DiSalvo G, Habib G, Pergola V, et al. Echocardiography predicts embolic events in infective endocarditis. J Am Coll Cardiol 2001;37:1069-1076
18. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991;114:635-640
19. Heinle S, Wilderman N, Harrison JK, et al. Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Duke Endocarditis Service. Am J Cardiol 1994;74:799-801
20. De Castro S, Magni G, Beni S et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997;80:1030-1034
21. Piper C, Wiemer M, Schulte HD, Horstkotte D. Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis 2001;10:703-711
22. Vilacosta I, Graupner C, San Roman JA, et al. Risk of embolization after institution of antibiotic therapy for infective endocarditis. J Am Coll Cardiol 2002;39:1489-1495
23. Horstkotte D, on behalf of the Task Force on Infective Endocarditis of the European Society of Cardiology. Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis: Executive Summary. Eur Heart J 2004;25:267-276
24. Erbel R, Liu F, Ge J, Rohmann S, Kupferwasser I. Identification of high-risk sub-groups in infective endocarditis and the role of echocardiography. Eur Heart J 1995;16:588-602
25. Rohmann S, Erbel R, Görge G, et al. Clinical relevance of vegetation localization by transesophageal echocardiography in infective endocarditis. Eur Heart J 1992;12:446-452
26. Martin-Davila P, Navas E, Fortun J, et al. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size. Am Heart J 2005;150;1099-1106
27. Robbins MJ, Frater RW, Soeiro R, et al. Influence of vegetation size on clinical outcome of right-sided infective endocarditis. Am J Med 1986;80:L165-L171
28. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992;117:560-566
29. Moon MR, Stinson EB, Miller DC. Surgical treatment of endocarditis. Prog Cardiovasc Dis 1997;40:239-264
30. Horstkotte D, Weist K, Rüden H. Better understanding of the pathogenesis of prosthetic valve endocarditis - recent perspectives for prevention strategies. J Heart Valve Dis 1998;7:313-315
31. Gutschik, E., and the Endocarditis Working Group of the International Society of Chemotherapy. Microbiological recommendations for the diagnosis and follow-up of infective endocarditis. Clin Microbiol Infect 1998;4(Suppl.3):S10-S16
32. Durack DT, Beeson PB. Experimental bacterial endocarditis. II. Survival of bacteria in endocardial vegetation. Br J Exp Pathol 1972;53:50-63
33. Frank V, Koppstein I, Schmidt-Eisenlohr E, et al. Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open heart surgery. Antimicrob Agents Chemother 1987;31:813-814
34. Piper C, Hetzer R, Körfer R, Bergemann R, Horstkotte D. The importance of secondary mitral valve involvement in primary aortic valve endocarditis: The mitral kissing vegetation. Eur Heart J 2002;23:79-86